Omada Health Celebrates Milestone Year with Record Growth and GAAP Profitability
Omada Health, a leading digital therapeutics company, has marked a significant milestone in its journey with a remarkable 53% revenue growth for the year 2025. The company's latest Q4 earnings conference call revealed that it achieved GAAP profitability for the first time in Q4 2025, solidifying its position as a major player in the digital health space.
As reported by Sean Duffy, Co-founder and CEO of Omada Health, 2025 was a defining year for the company. The significant revenue growth, coupled with GAAP profitability, is a testament to the company's strong market presence and innovative approach to digital therapeutics. With over 886,000 members at the end of 2025, up 55% compared to 2024, Omada Health has demonstrated its ability to scale and expand its reach.
The company's Q4 revenue grew by a staggering 58%, reaching $260 million for the quarter. This impressive growth can be attributed to the convergence of strong market tailwinds, a decade of investments in technology and operational platforms, clinical programs, peer-reviewed research, productive distribution channels, and rich data. As Duffy noted, "Omada's technology and operational platform, our clinical programs, our peer-reviewed research, productive distribution channels, and more than a decade of rich and unique data are strongly suited for this exact moment." The company's AI-driven innovation has enabled it to capture the momentum created by customer demand for chronic care solutions and the rapidly evolving GLP-1 marketplace.
The success of Omada Health extends beyond financial metrics. As highlighted during the conference call, the company's mission is to bend the curve of obesity-related disease. With over 40% of adults living with obesity and nearly two-thirds having at least one cardiometabolic risk factor, Omada Health has taken a fundamental approach to addressing this issue through its integrated multi-condition care model. This model brings together care teams, AI, connected devices, and a custom care platform designed for quality at scale.
The company's focus on delivering high-quality care is evident in the testimonials from satisfied customers. As one member shared, "The Omada program, in collaboration with my doctor and the use of GLP-1 meds, has been life-changing. I learned real skills needed to lose weight and be healthy for a lifetime." This success story is a testament to the impact of Omada Health's approach on individuals' lives.
Omada Health's future prospects look promising, with a clear plan in place for what's next. As Duffy emphasized, "We believe that 2025 demonstrated how we can capture that momentum." The company's commitment to innovation, quality care, and growth positions it as a leader in the digital health space.
